75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - PIPE Financing and de-SPAC Transaction link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements and Disclosures link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - In-Licensing and Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Income from Transition Services Agreements link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - PIPE Financing and de-SPAC Transaction (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Fair Value Measurements and Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Redemption Reflected (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Summary of Significant Accounting Policies - Schedule of Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Summary of Significant Accounting Policies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - PIPE Financing and de-SPAC Transaction (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - PIPE Financing and de-SPAC Transaction - The Company's Outstanding Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Fair Value Measurements and Disclosures - Schedule of Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Fair Value Measurements and Disclosures (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Fair Value Measurements and Disclosures - Schedule of Participation Right Liability (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Fair Value Measurements and Disclosures - Schedule of Probability Weighted Expected Return Method (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Fair Value Measurements and Disclosures - Schedule of Amortized Cost and Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - In-License and Collaboration Agreements (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Out-licensing and Collaboration Agreements (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Income from Transition Services Agreements (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Commitments and Contingencies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' (Deficit) - Schedule of Redeemable Convertible Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - Schedule of Shares Reserved for Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Leases - Schedule of Amortization of Company's Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Leases - Schedule of Amortization of Company's Lease Liabilities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Leases (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Stock-Based Compensation - Schedule of stock-based compensation expense categories (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Stock-Based Compensation - Schedule of stock based compensation (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Stock-Based Compensation - Schedule of stock option activity (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Stock-Based Compensation - Summary of fair value of each option grant estimated throughout year using black-scholes option-pricing model (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Stock-Based Compensation - Summary of Activity under the 2025 Plan with respect to the Company's RSUs (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Stock-Based Compensation (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Income Taxes (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Related Party Transactions (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Weighted Average Grant Date Fair Value, Vested and released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited and cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Debt Securities Available for Sale Estimated Fair Value Debt Securities Available for Sale Estimated Fair Value Estimated Fair Value Accrued Employee Benefits, Current Accrued compensation and benefits Two Thousand Sixteen Plan [Member] Two Thousand Sixteen Plan [Member] 2016 Plan Share Based Compensation Arrangement By Equity Awards Issued By BridgeBio Pharma Share Based Compensation Arrangement By Equity Awards Issued By BridgeBio Pharma Equity awards issued by BridgeBio Pharma Entity Incorporation, State or Country Code Preferred Stock, Shares Issued Shares issued Preferred stock, shares issued Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Summary of assets and liabilities measured at fair value on a recurring basis Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total Accounts payble Revision of Prior Period [Axis] Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosures of non-cash investing and financing activities: Plan Name [Axis] Research and Development Expense [Abstract] Common stock of Helix issued in the PIPE Financing Common Stock Of Helix Issued In The PIPE Financing Common Stock Of Helix Issued In The PIPE Financing Equity [Abstract] Entity Current Reporting Status Increase (Decrease) in Professional Fee Payable Accrued professional services Operating Expenses [Abstract] Operating expenses: Level 2 Fair Value, Inputs, Level 2 [Member] Unpaid Property and Equipment Included in Other Accrued Liabilities Unpaid Property and Equipment Included in Other Accrued Liabilities Unpaid property and equipment included in accounts payable and other accrued liabilities Unvested Restricted Stock Units of Common Stock [Member] Unvested Restricted Stock Units of Common Stock [Member] Unvested RSU's of common stock Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common stock, shares authorized Option Indexed to Issuer's Equity, Type [Axis] Earnings Per Share, Basic [Abstract] Transaction costs Represent amount of transaction costs. Transaction Costs Document Fiscal Period Focus Entity Shell Company Other accrued liabilities Other Accrued Liabilities, Current Facilities And Other Expenses [Member] Facilities And Other Expenses [Member] Cash Payment to an Executive Contingent Payment for Other Operating Activity Segment Reporting, Policy [Policy Text Block] Segments Cash and Cash Equivalent Cash and Cash Equivalent, Total Cash and cash equivalents Research and Development Arrangement, Contract to Perform for Others [Table Text Block] Schedule of Research and Development Expense Notes Payable, Current Payables to related parties Cash underwriting fee Represent the amount of cash underwriting fee. Cash Underwriting Fee Common stock, shares issued Common Stock, Shares, Issued Common stock, shares issued Lessee, Operating Lease, Description Lessee Operating Lease Description Asset Class [Domain] Statement [Table] Redeemable Convertible Preferred Stock On An As Converted Into Common Stock Basis [Member] Redeemable Convertible Preferred Stock On An As Converted Into Common Stock Basis [Member] Redeemable convertible preferred stock on an as-converted into common stock basis Restricted Cash, Noncurrent Restricted cash Right-of-use asset recognized in exchange for operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Prepaid expense and other currents assets Increase (Decrease) in Prepaid Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value weighted-average grant granted Accrued interest in marketable securities Amount on accrued Interest on marketable securities. Accrued Interest On Marketable Securities Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Reduction in fair valuse percentage Leidos Biomedical Research License And Cooperative Research And Development Agreements [Member] Leidos Biomedical Research License And Cooperative Research And Development Agreements [Member] Leidos CRADA [Member] Statement [Line Items] Business Combination [Domain] Entity Filer Category General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Liabilities and Equity Total liabilities, redeemable convertible preferred stock, and stockholders' equity Accrued compensation and benefits Increase (Decrease) in Employee Related Liabilities Increase (Decrease) in Employee Related Liabilities, Total Purchases of marketable securities Payments to Acquire Marketable Securities Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable as of June 30, 2026 License And Collaboration Agreements [Abstract] License And Collaboration Agreements [Abstract] Issued and outstanding voting securities Business Combination, Voting Equity Interest Acquired, Percentage Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure Interest earned on marketable securities held in Trust Account Interest earned on marketable securities held in Trust Account Interest earned in trust account Investment Income, Interest Unpaid property and equipment included in accounts payable and other accrued liabilities Contribution of Property Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents, and Restricted Cash Allowance for credit losses Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss, Ending Balance Accounts Receivable, Allowance for Credit Loss, Beginning Balance Long-Term Marketable Securities [Member] Long-Term Marketable Securities [Member] Long-Term Marketable Securities Related Party [Member] Related Party [Member] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Transition Services Agreement [Member] Transition Services Agreement [Member] Transition Services Agreement [Member] Share Based Compensation Arrangement By Performance Based Milestone Awards Share Based Compensation Arrangement By Performance Based Milestone Awards Performance-based milestone awards Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of options granted Schedule of Basic and Diluted Net (Loss) Income Per Ordinary Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Dividends Payable Dividends declared or paid Basic net income per ordinary share Earnings Per Share, Basic Net loss per share attributable to common stockholders, basic Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Beginning Balance Ending Balance Weighted average grant date fair value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Inducement Plan [Member] 2025 Inducement Plan [Member] 2025 Inducement Plan [Member] Total current liabilities Liabilities, Current Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Payroll And Personnel Expenses [Member] Payroll And Personnel Expenses [Member] Accrued Research and Development Costs Current Accrued research and development costs current. Accrued research and development liabilities Research And Collaboration Agreement [Member] Research And Collaboration Agreement [Member] Research And Collaboration Agreement Equity, Attributable to Parent [Abstract] Stockholders' equity (deficit): Entity Small Business Less: Redeemable Noncontrolling Interest, Equity, Carrying Amount [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Recently Adopted Accounting Pronouncements Recently Adopted Accounting Pronouncements [Policy Text Block] Recently Adopted Accounting Pronouncements [Policy Text Block] Commitments and Contingencies [Line Items] Other Commitments [Line Items] Nature of Operations [Text Block] Organization Preferred Stock [Member] Preferred Stock Gross proceeds Proceeds from Issuance Initial Public Offering Share price per share (in Dollars per share) Share purchase price (in Dollars per share) Fair value price per share (in Dollars per share) Sale of Stock, Price Per Share Payables to related parties Payables To Related Parties Payables To Related Parties Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Description of Organization and Business Operations [Abstract] Leases [Abstract] Class A Ordinary Shares Class A Class A Ordinary Shares [Member] Class A [Member] Contract with Customer, Liability Contract with Customer, Liability, Total Contract With Customer Liability Amendment Flag Net Loss per Share Attributable to Common Stockholders Earnings Per Share, Policy [Policy Text Block] Entity Address, Postal Zip Code Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Increase (Decrease) in Operating Lease Liability Operating lease liabilities Debt Instrument, Redemption Price, Percentage Debt Instrument, Redemption Price, Percentage Interest to pay dissolution expenses Interest to pay dissolution expenses. Interest To Pay Dissolution Expenses Common Stock [Member] Common Stock Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Description of the Business Business Description and Accounting Policies [Text Block] Entity Address, Address Line One Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Class A ordinary shares subject to possible redemption, 18,400,000 shares at redemption value of $10.68 and $10.46 per share as of June 30, 2025 and December 31, 2024, respectively Class A ordinary shares subject to possible redemption Temporary Equity, Carrying Amount, Attributable to Parent Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block] Redeemable Convertible Preferred Stock Payment of fees and expenses Payments for Underwriting Expense Proceeds to net of underwriting discount Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Document Type Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Central Index Key Restricted Cash and Cash Equivalent [Abstract] Minimum maturity term The maximum maturity term of investments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Minimum Maturityof Investment Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net increase in cash, cash equivalents, and restricted cash Interest income Interest Income, Operating Interest Income, Operating, Total Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares Reserved for Issuance Offering Price Related to Series B Offering Price Related to Series B Offering Price Related to Series B APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Stock-based compensation Other Non Cash Adjustments, Net Other Non Cash Adjustments, Net Other non cash adjustments, net Common Stock, Par or Stated Value Per Share Common stock, par value (in Dollars per share) Liability Liabilities [Abstract] Net proceeds from sale of units Net proceeds from sale of units. Net Proceeds From Sale Of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (Years) , Balance Debt Securities, Available-for-Sale, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Total Amortized Cost Basis Redemption Of Helix Common Stock Redemption Of Helix Common Stock Redemption of Helix common stock BridgeBio Pharma [Member] BridgeBio Pharma [Member] BridgeBio Pharma BridgeBio Pharma Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of options exercised Exercise of common stock options for cash Number of Options, Exercised Restricted cash [Member] Restricted cash [Member] Restricted cash [Member] Legacy BBOT Common Stock Legacy BBOT Common Stock Legacy BBOT common stock Marketable Securities Long-term marketable securities Total marketable securities Estimated Fair Value Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Share Based Compensation Expense Carve Out Methodology Share Based Compensation Expense Carve Out Methodology Amounts recognized under the carve-out methodology Milestone Payment Milestone Liability Milestone Liability Document Quarterly Report Restricted Cash and Cash Equivalents [Axis] Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Beginning Balance Number of Shares, Ending Balance Stock Issued During Period, Value, Conversion of Convertible Securities Conversion of Series B redeemable convertible preferred stock into common stock, Value Increase (Decrease) in Other Accrued Liabilities Other accrued liabilities Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Shares Outstanding Preferred stock, shares outstanding Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Common Stock, Capital Shares Reserved for Future Issuance Common Stock Shares Reserved Conversion of Stock, Shares Converted Outstanding and unexercised common stock converted into aggregate common stock Marketable Securities, Current Short-term marketable securities Estimated Fair Value, Short Term Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-based compensation expense Professional Fees Professional Fees Stock Issued During Period, Value, Stock Options Exercised Exercise of common stock options for cash (Amount) Comprehensive Income, Policy [Policy Text Block] Other Comprehensive Income or Loss Collaborative Arrangement Disclosure [Text Block] In-Licensing and Collaboration Agreements Proceeds from Sale and Maturity of Marketable Securities Maturities and sales of marketable securities Marketable Securities, Policy [Policy Text Block] Marketable Securities Redeem public shares, percentage Redeem public shares, percentage. Public Shares Percentage Short-Term Marketable Securities [Member] Short-Term Marketable Securities [Member] Short-Term Marketable Securities Other Assets, Noncurrent Other non-current assets Proceeds from Issuance of Convertible Preferred Stock Issuance of Series B redeemable convertible preferred stock, net of issuance costs Antidilutive Securities [Axis] Schedule Of Class AOrdinary Shares Subject To Redemption Reflected [Abstract] Milestone Payments Under In Licensing Agreements [Policy Text Block] Milestone Payments Under In Licensing Agreements [Policy Text Block] Milestone Payments Under In-Licensing Agreements Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income Cash [Member] Cash [Member] Cash and Cash Equivalents [Domain] Participation Right Liability [Policy Text Block ] Participation Right Liability [Policy Text Block ] Participation Right Liability Plus: Temporary Equity, Including Noncontrolling Interest [Abstract] Business Combination [Member] Business Combination [Member] Preferred Stock, Value, Issued Preference stock, value Carrying Value Working capital loans Working capital loans (in Dollars) Working capital loan. Working Capital Loan Minimum [Member] Minimum Minimum [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Financial Instrument [Axis] Assets, Current [Abstract] Current assets: RCA License Grant [Member] RCA License Grant [Member] RCA License Grant [Member] Class B Ordinary Shares Class B Class B [Member] Class B Ordinary Shares [Member] Fair Value, Inputs, Level 3 [Member] Level 3 Repayments of Other Debt Performance Cash Bonus Payment Segment Information [Abstract] Business Combination [Policy Text Block] Asset Acquisitions Unrealized Gain (Loss) on Investments Unrealized loss position Current liabilities Liabilities, Current [Abstract] Disclosure of accounting policy for emerging growth company. Emerging Growth Company [Policy Text Block] Emerging Growth Company Status Stock Option and Incentive Plan [Member] Stock Option and Incentive Plan [Member] Stock Option And Incentive Plan [Member] Related Party Transactions [Abstract] Balance (in Shares) Balance (in Shares) Shares, Outstanding Other Income Lessee, Operating Lease, Renewal Term Renewal Term Summary of Significant Accounting Policies (Details) [Table] Restricted Cash and Cash Equivalent Total cash, cash equivalents, and restricted cash Legacy BBOT Common Stock Option Legacy BBOT Common Stock Option Legacy BBOT common stock option Commitments and Contingencies Commitments and contingencies (Note 7) Lessee, Leases [Policy Text Block] Leases Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Beginning Balance Weighted Average Grant Date Fair Value, Ending Balance General and administrative General and Administrative Expense [Member] Total operating lease liabilities Operating Lease, Liability Related Party Income and Expenses [Member] Related Party Income and Expenses [Member] Related Party Income and Expenses Marketable Securities, Noncurrent Estimated Fair Value, Long Term Long-term marketable securities Royalty Guarantees, Commitments, Amount Royalty commitments amount Common Stock Options [Member] Common Stock Options [Member] Common Stock Options [Member] Probability Weighted Expected Return Method Series B Probability Weighted Expected Return Method Series B Schedule of Probability-Weighted Expected Return Method Weighted-average shares outstanding basic Weighted Average Number of Shares Outstanding, Basic Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic Restrictions on Cash and Cash Equivalents [Table] Trust account share price (in Dollars per share) Represent the amount of trust account public price. Trust Account Public Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exercisable as of June 30, 2026 Share-Based Payment Arrangement, Plan Modification, Incremental Cost Incremental stock-based compensation expense Series B [Member] Series B Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Aggregate private placement Aggregate purchase price Proceeds from Issuance of Private Placement Proceeds from reverse recapitalization and PIPE Financing Related Party Transactions Disclosure [Text Block] Related Party Relationships Cash Cash Balance Balance Equity, Attributable to Parent Total stockholders' equity Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Redeemable convertible preferred stock purchase price Investment Category [Domain] Investment Category [Domain] Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and Principles of Consolidation Statement of Stockholders' Equity [Abstract] Deferred de-SPAC transaction costs included in accrued professional services and other accrued liabilities Deferred De-SPAC Transaction Costs Included in Accrued Professional Services and Other Accrued Liabilities Deferred De-SPAC Transaction Costs Included in Accrued Professional Services and Other Accrued Liabilities Deferred de-SPAC transaction costs included in accrued professional services and other accrued liabilities Interest and Other Income [Text Block] Income from Transition Services Agreements Cash Equivalents [Member] Cash Equivalents [Member] Cash Equivalents Series A [Member] Series A Preferred Stock [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Over-Allotment Option [Member] Over-Allotment Option [Member] Research And Development Expenses Include Related Party Research And Development Expenses Include Related Party Entity Address, Address Line Two Fair Value Disclosures [Text Block] Fair Value Measurements and Disclosures Entity Incorporation, Date of Incorporation Participation Right Liability Participation Right Liability Participation right liability Participation right liability Participation Right Liability, Beginning Balance Participation Right Liability, Ending Balance Shares reserved for issuance under the inducement plan [Member] Shares reserved for issuance under the inducement plan Shares available for issuance under the inducement plan Plan Name [Domain] Schedule of Research and Development Expenses [Table Text Block ] Schedule of Research and Development Expenses [Table Text Block ] Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Summary of fair value of each option grant estimated throughout year using black-scholes option-pricing model Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number Stock options for accelerated vesting Receivable [Policy Text Block] Receivables from and Payables to Related Parties Entity [Domain] Shares reserved for issuance under stock option and incentive plan [Member] Shares reserved for issuance under stock option and incentive plan [Member] Shares reserved for issuance under stock option and incentive plan Certificates of Deposit [Member] Certificated of Deposit Related and Nonrelated Parties [Axis] Consideration Ratio Consideration Ratio Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment, net Area of Real Estate Property Area of office space Entity Address, City or Town Federal depository insurance coverage Cash, FDIC Insured Amount Payments for Participation Liabilities Settlement of participation right liability Settlement of participation right liability upon issuance of Series B redeemable convertible preferred stock Security Exchange Name Schedule of Class A Ordinary Shares Subject to Redemption Reflected Temporary Equity [Table Text Block] Liability for Unpaid Claims and Claims Adjustment Expense, Net Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance Milestone Payment PIPE Financing and de-SPAC Transaction [Text Block] PIPE Financing and de-SPAC Transaction [Text Block] PIPE Financing and de-SPAC Transaction Auction Market Preferred Securities, Stock Series [Axis] Counterparty Name [Axis] Fair Value Measurements [Table] Fair Value Measurements [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Weighted average grant date fair value, Forfeited Antidilutive Securities, Name [Domain] Helix Common Stock Subject To Redemption Prior To The Closing Helix Common Stock Subject To Redemption Prior To The Closing Helix common stock subject to redemption prior to the Closing Cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement [Domain] Total current assets Assets, Current Share-Based Payment Arrangement, Expense Total Common stock options issued by the Company Share Based Compensation Arrangement By Common stock options issued by the Company Share Based Compensation Arrangement By Common stock options issued by the Company Document Period End Date Other Income and Expenses [Abstract] Fair Value Hierarchy and NAV [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable as of June 30, 2026 Unrealized gains or losses on cash equivalents Unrealized Gain (Loss) on Price Risk Cash Flow Derivatives, before Tax Unrealized Gain (Loss) on Price Risk Cash Flow Derivatives, before Tax, Total Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) [Member] Restricted Stock Units ("RSU"s) unvested and expected to vest Restricted Stock Units [Member] Revenue [Policy Text Block] Revenue Recognition Redeemable Convertible Preferred Stock [Member] Redeemable convertible preferred stock Redeemable convertible preferred stock on an as-converted into common stock basis Antidilutive Security, Excluded EPS Calculation [Table] Lawrence Livermore National Security, LLC [Member] Lawrence Livermore National Security, LLC [Member] Class of Stock [Axis] Other Assets, Fair Value Disclosure Fair Value In Process Research and Development, Policy [Policy Text Block] Accrued Research and Development Liabilities Schedule of Shares Reserved for Issuance [Table Text Block] Schedule of Shares Reserved for Issuance [Table Text Block] Schedule of Shares Reserved for Issuance Liabilities Total liabilities Total liabilities Financial Instruments [Domain] Capital Units, Authorized Authorized Amount Equity Method Investments [Policy Text Block] Equity Method Investment Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Restricted Cash and Cash Equivalent Item [Line Items] Restricted Cash Restricted cash Restricted Cash, Total Change in fair value of participation right liability Increase (Decrease) in Participation Liabilities Change in fair value of participation right liability Weighted-average shares outstanding diluted Weighted Average Number of Shares Outstanding, Diluted Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted Increase (Decrease) in Due from Related Parties Increase (Decrease) in Due from Related Parties, Total Balances due to and from related parties Entity File Number Cover [Abstract] Remains Diluted Outstanding Capitalization Remains Diluted Outstanding Capitalization Remains Diluted Outstanding Capitalization Diluted Outstanding Capitalization Diluted Outstanding Capitalization Representing Diluted Outstanding Capitalization Prepaid Expense and Other Assets, Current Prepaid expense and other current assets Total prepaid expenses and other current assets Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of Shares, Forfeited and cancelled License Maintenance Fees Cost, Direct Tax and License Operating segment Number of Operating Segments Sale of Stock [Domain] Deferred de-SPAC transaction costs included in accrued professional services and other accrued liabilities Professional and Contract Services Expense SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Allocated Operating Expenses [Member] Allocated Operating Expenses [Member] Allocated Operating Expenses General and Administrative Expense General and Administrative Expense, Total General and administrative expenses General and administrative Series B Preferred Stock [Member] Series B Preferred Stock Series B [Member] Original Issue Price Per Share Preferred Stock, Convertible, Conversion Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Number of options vested Vested and released Shares Purchase Percentage Shares Purchase Percentage Shares Purchase Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total Forfeited and cancelled Forfeited and cancelled Stock Issued During Period, Shares, Other Stock Issued During Period Shares Other Marketable Securities [Abstract] Marketable securities: Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance unvested common stock options New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Schedule of amortization of Company's lease liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of Series B redeemable convertible preferred stock into common stock, Shares Research And Development Trials And Consumables Expense [Member] Research And Development Trials And Consumables Expense [Member] Payment of deferred transaction costs Payment of Financing and Stock Issuance Costs Payment of Financing and Stock Issuance Costs, Total Redeemable convertible preferred stock included the fair value Mandatorily Redeemable Preferred Stock, Fair Value Disclosure Total Common Stock Issued And Outstanding Total Common Stock Issued And Outstanding Total common stock issued and outstanding Total common stock issued and outstanding Depreciation Depreciation, Total Depreciation of property and equipment Percentage of redeem public shares Percentage of redemption in connection with initial public shares. Percentageof Redemptionin Connection With Initial Public Shares Underwriting discounts Represents the value of underwriting discounts. Underwriting Discounts Price per share (in Dollars per share) Initial Public Offering price per Share. Initial Public Offering Price Per Share Lessee, Operating Lease, Term of Contract Lease Term Common Stock, Shares, Outstanding Common shares, shares outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Total common stock outstanding Operating Lease, Liability, Current Operating lease liability, current Description of Organization and Business Operations [Line Items] Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Document Transition Report Operating Expenses Total operating expenses Research and Development Expense Total research and development Research and development Research and development expense Asset Impairment Charges Asset Impairment Charges, Total Impairment charges Cost of Revenue Cost of Revenue, Total Cost of Revenue Lessee, Operating Leases [Text Block] Leases Statement of Cash Flows [Abstract] Shares issuable under the participation right Shares Issuable Under The Participation Right [Member] Shares Issuable Under The Participation Right [Member] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of common stock options outstanding Preferred Stock, Liquidation Preference, Value Aggregate Liquidation Preference Preferred stock, liquidation preference, value Equity [Text Block] Redeemable Convertible Preferred Stock and Stockholders' Deficit Earnings Per Share [Text Block] Net Loss Per Share Attributable to Common Stockholders Schedule of Class A Ordinary Shares Subject to Redemption Reflected [Line Items] Schedule of Activity under the 2025 Plan with respect to the Company's RSUs Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Net loss Net loss Net loss Net losses Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Beginning Balance Ending Balance Preferred Stock, Convertible, Shares Issuable Preferred Stock Convertible Shares Issuable Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividends Reduction price (in Dollars per share) Represent the per share amount of trust account due to reduction price. Trust Account Due To Reduction Price Substantial Doubt about Going Concern [Text Block] Liquidity ASSETS Assets [Abstract] Assets Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Intrinsic Value Intrinsic Value Intrinsic value Shares Reserved For Issuance Shares Reserved For Issuance Shares reserved for issuance Document Fiscal Year Focus Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Investing activities Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Research and Development Expense [Member] Research and development Increase (Decrease) in Other Noncurrent Assets Other non-current assets Revision of Prior Period [Domain] Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Proceeds from Stock Options Exercised Exercise of common stock options for cash Fair Value Measurements [Abstract] Commitments and Contingencies Disclosure [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Sublicensing Income Proceeds from License Fees Received Purchase aggregate value Sale of Stock, Consideration Received on Transaction Issuance Of Series B Redeemable Convertible Preferred Stock For Cash Consideration And Settlement Of Participation Right Liability Share Issuance of Series B Redeemable Convertible Preferred Stock for Cash Consideration and Settlement Of Participation Right Liability Share Issuance of Series B redeemable convertible preferred stock for cash consideration and settlement of participation right liability, Share No Performance Milestone Awards No Performance Milestone Awards No performance milestone awards Working capital deficit The amount of working capital deficit. Working Capital Deficit Share-Based Payment Arrangement [Abstract] Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Total assets Sale of Stock [Axis] Series Seed [Member] Series Seed [Member] Series Seed [Member] Helix common stock held by the Sponsor Helix Common Stock Held By The Sponsor Helix Common Stock Held By The Sponsor Share Based Compensation Arrangement By Share Based Payment Award Performance Base Awards Expense Share Based Compensation Arrangement By Share Based Payment Award Performance Base Awards Expense Performance-based milestone awards Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash (used in) provided by investing activities Private Placement Shares [Member] Private Placement [Member] Private Placement [Member] Deferred de-SPAC Transaction Costs [Policy Text Block] Deferred de-SPAC Transaction Costs [Policy Text Block] Deferred de-SPAC Transaction Costs Title of 12(b) Security Probability of a qualifying liquidity event Qualifying Liquidity Event Probability Qualifying Liquidity Event Probability weighted-average grant-date fair vested and forfeiture Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Forfeited and cancelled Money market funds Money Market Funds [Member] Percentage of restricted redeeming shares Restricted Investments, Percent of Net Assets Related and Nonrelated Parties [Domain] Description of Organization and Business Operations (Details) [Table] Income Tax Disclosure [Text Block] Income Taxes Debt Securities, Available-for-Sale, Allowance for Credit Loss Debt Securities, Available-for-Sale, Allowance for Credit Loss, Ending Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss, Beginning Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss, Total Allowance for credit losses Collaborative Arrangement and Arrangement Other than Collaborative [Table] Common Stock Options Issued and Outstanding [Member] Common Stock Options Issued and Outstanding [Member] Common stock options issued and outstanding Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (six months) Legal Entity [Axis] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Beginning Balance Ending Balance Other offering costs Represent the amount offering costs. Offering Costs Income Tax Disclosure [Abstract] Participation Right Liability [Table Text Block] Participation Right Liability [Table Text Block] Schedule of Participation Right Liability Additional Paid-in Capital Additional Paid-in Capital [Member] Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued research and development liabilities Amortization of Regulatory Asset Amortization of right-of-use assets Measurement Frequency [Domain] Statement of Income Location, Balance [Axis] Summary of Significant Accounting Policies [Line Items] Trading Symbol Related Party Transaction [Table] Outstanding Common Stock Options [Member] Outstanding Common Stock Options [Member] Outstanding Common Stock Options [Member] Participation Costs, Policy [Policy Text Block] Participation Right Liability Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Financing activities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term, years Fair Value, Recurring [Member] Recurring Basis Entity Ex Transition Period Lessee, Operating Lease, Liability, to be Paid Total lease payments Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Equity Components [Axis] Nonoperating Income (Expense) Total other income, net Equity Component [Domain] Share-Based Payment Arrangement, Activity [Table Text Block] Schedule of Stock-based compensation components Asset Class [Axis] Class of Stock Disclosures [Abstract] Business Combination [Axis] Initial Public Offering [Member] IPO [Member] IPO [Member] Proceeds from Partnership Contribution Contribution from BridgeBio Pharma Fund Contribution University Of California License Agreements [Member] University Of California License Agreements [Member] UCSF License [Member] Collaborative Arrangement, Accounting Policy [Policy Text Block] Collaborative Arrangements US Treasury and Government [Member] Treasury Bills Statement of Comprehensive Income [Abstract] Receivables from related parties Accounts and Other Receivables, Net, Current Liquidity Policies [Text Block] Liquidity Policies Liquidity Maximum [Member] Maximum Maximum [Member] Debt Instrument, Convertible, Conversion Ratio Ratio of Capital Stock Converted Into Common Stock Schedule of Stock by Class [Table Text Block] Schedule of Redeemable Convertible Preferred Stock Statistical Measurement [Axis] Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Weighted Average Period Share Based Compensation Arrangements By Share Based Payment Award Options Weighted Average Period Common Stock, Value, Issued Fair value of common stock issuable to related party Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 80,088,931 and 79,991,768 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Deferred underwriting fees Represent the amount of deferred underwriting fees. Deferred Underwriting Fees Cash and Cash Equivalents [Abstract] Cash equivalents: Payments for Other Fees Cash fees Percentage of fair market value Minimum percentage of fair market value of business acquisition to trust account balance. Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive loss, net of tax: Probability Weighted Expected Return Method Table Text Block Probability Weighted Expected Return Method Table Text Block Schedule of Probability-Weighted Expected Return Method Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Cash Bonus Payment Amount Cash Bonus Payment Amount Cash bonus payment amount Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Preferred Stock, Shares Authorized Shares authorized Preferred stock, shares authorized Accretion of carrying value to redemption value Temporary Equity, Accretion to Redemption Value, Adjustment Related Party Transactions [Line Items] Entity Registrant Name Leidos Biomedical Research, Inc. [Member] Leidos Biomedical Research, Inc. [Member] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Other income (expense) Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Additional paid-in capital Additional Paid in Capital Interest in marketable securities Interest in marketable securities. Interest In Marketable Securities Public Shares [Member] Public Shares [Member] Deposit account Deposit Assets Tax provision Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Provision for income tax Black-Scholes [Member] Black-Scholes [Member] Measurement Frequency [Axis] Proceeds from Issuance of Common Stock Proceeds from Issuance of Common Stock Upfront Fees Upfront Fees Upfront Fees Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Other General Expense Material expenses Entity Common Stock, Shares Outstanding Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk and Other Risks and Uncertainties Accrued Milestone Compensation Arrangements Compensation Related Costs, Policy [Policy Text Block] Contra [Member] Contra [Member] Contra [Member] Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive income (loss) Taxes payable to interest to pay dissolutions expenses Taxes paid or payable interest to pay dissolution expenses. Taxes Paidor Payable Interest To Pay Dissolution Expenses Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Revenue from collaborative arrangement with related party Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Net Asset Value Per Share Net Asset Value Per Share, Ending Balance Net Asset Value Per Share, Beginning Balance Net asset value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of Restrictions on Cash and Cash Equivalents Temporary Equity, by Class of Stock [Table] Assets Total assets Total assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable as of June 30, 2026 Income Statement [Abstract] Treasury bills Treasury Bills [Member] Treasury Bills [Member] Schedule of Research and Development Expense [Table Text Block] Schedule of Research and Development Expense [Table Text Block] Schedule of Research and Development Expense Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Legal Fees Legal fees Number of units issued in transaction (in Shares) Amount of public shares Exchanged shares Sale of Stock, Number of Shares Issued in Transaction Stock issued shares (in Shares) Stock Issued During Period, Shares, New Issues Shares issuable under the participation right Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Shares, Vested and released Vesting of restricted stock, Share Diluted net income per ordinary share Earnings Per Share, Diluted Net loss per share attributable to common stockholders, diluted Fair Value Measurements [Line Items] Auction Market Preferred Securities, Stock Series, Title [Domain] Schedule of Performance and Making Key Decisions Regarding Resource Allocation Schedule of Segment Reporting Information, by Segment [Table Text Block] City Area Code Unrealized Gains Or Losses Unrealized Gains Or Losses Unrealized gains or losses Materail changes Material Changes Amount Material Changes Amount Options Held [Member] Options Held [Member] Counterparty Name [Domain] General And Administrative Expenses Include Related Party General And Administrative Expenses Include Related Party Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Lease Expiration Date Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Total Property and equipment, net Loss from operations Operating Income (Loss) Material Related Party Transactions Transaction between Entities under Common Control [Policy Text Block] Accumulated Deficit Retained Earnings [Member] Cash and Cash Equivalents [Axis] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-Based Payment Arrangement, Noncash Expense, Total Stock-based compensation Public Shares issuance costs Payments of Stock Issuance Costs TSA TSA Amendment [Member] TSA Amendment [Member] Collaboration Agreements [Abstract] Collaboration Agreements [Abstract] Operating Lease, Weighted Average Discount Rate, Percent Weighted average remaining lease term discount rate Operating Lease, Liability, Noncurrent Operating lease liability, noncurrent Fair Value, Inputs, Level 1 [Member] Level 1 Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Schedule of Conversions of Stock [Table Text Block] Schedule of Shares Reserved for Issuance Nonoperating Income (Expense) [Abstract] Other income, net: Milestone Payment Milestone payment Milestone payment Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Corporate Debt Securities [Member] Corporate Debt Securities Lawrence Livermore National Security License And Cooperative Research And Development Agreements [Member] Lawrence Livermore National Security License And Cooperative Research And Development Agreements [Member] LLNS CRADA [Member] Entity Interactive Data Current Statement of Income Location, Balance [Domain] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Operating activities Accretion (Amortization) of Discounts and Premiums, Investments Net accretion of premiums and discounts on marketable securities Discount rate Discount Rate Discount Rate Cash Equivalents, at Carrying Value Cash Equivalents, at Carrying Value, Total Cash equivalents Option Indexed to Issuer's Equity, Type [Domain] Investment Category [Axis] Investment Category [Axis] Entity Tax Identification Number Share Price Schedule of Common Stock Outstanding Roll Forward [Table Text Block] The Company's Outstanding Common Stock Promptly business days Represents the threshold number of business days to redeem Public Shares from Combination Period if the Company has not completed an Initial Business Combination. Threshold Numberof Business Daysto Redeem Public Shares From Combination Period Trust Account [Member] Trust Account [Member] Marketable Security, Unrealized Gain (Loss) Unrealized losses on marketable securities Unrealized gains (losses) on marketable securities Unrealized gain (loss) on marketable securities Income From Transition Services Agreements Income from transition services agreements Income From Transition Services Agreements Local Phone Number Related Party Transaction [Domain] Unrecognized stock based expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Short-Term Lease, Cost Short-term lease costs Servicing Asset at Amortized Cost [Table Text Block] Schedule of Amortized Cost and Fair Value Shares Purchase Percentage Revenue, Remaining Performance Obligation, Percentage Shares Reserved For Issuance Under The Employee Stock Purchase Plan [Member] Shares Reserved For Issuance Under The Employee Stock Purchase Plan [Member] Shares reserved for issuance under the employee stock purchase plan Summary of Significant Accounting Policies [Abstract] Previously Reported [Member] Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Committed cash bonus amount Committed Cash Bonus Amount Committed Cash Bonus Amount Class of Stock [Domain] Commercial Paper [Member] Commercial Paper Weighted average period, unvested common stock options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Accrued Professional Fees, Current Accrued professional services cash, cash equivalents, and marketable securities Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Issuance Of Series B Redeemable Convertible Preferred Stock For Cash Consideration And Settlement Of Participation Right Liability Issuance Of Series B Redeemable Convertible Preferred Stock For Cash Consideration And Settlement Of Participation Right Liability Issuance of Series B redeemable convertible preferred stock for cash consideration and settlement of participation right liability Stock, Class of Stock [Table] Entity Emerging Growth Company Revision of Prior Period, Accounting Standards Update, Adjustment [Member]